Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127045141 | 12704514 | 1 | I | 20110816 | 20160823 | 20160831 | 20160831 | EXP | BR-GLAXOSMITHKLINE-BR2016GSK124927 | GLAXOSMITHKLINE | 89.82 | YR | F | Y | 0.00000 | 20160831 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127045141 | 12704514 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 PUFF(S), QD | Y | 21077 | 2 | DF | INHALATION POWDER | QD | |||||
| 127045141 | 12704514 | 2 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 2 UNK, BID | 0 | 2 | DF | OROMUCOSAL SPRAY | BID | |||||||
| 127045141 | 12704514 | 3 | SS | Marevan | WARFARIN SODIUM | 1 | U | U | 0 | ||||||||||
| 127045141 | 12704514 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | U | 0 | ||||||||||
| 127045141 | 12704514 | 5 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | U | 0 | |||||||||||
| 127045141 | 12704514 | 6 | C | QUETIAPINE. | QUETIAPINE | 1 | Oral | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 127045141 | 12704514 | 7 | C | Atorvastatin | ATORVASTATIN | 1 | Oral | 1 UNK, QD | U | 0 | 1 | DF | QD | ||||||
| 127045141 | 12704514 | 8 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.5 MG, QD | U | 0 | .5 | MG | QD | ||||||
| 127045141 | 12704514 | 9 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 1 UNK, QD | U | 0 | 1 | DF | QD | ||||||
| 127045141 | 12704514 | 10 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | U | 0 | ||||||||||
| 127045141 | 12704514 | 11 | C | OXYGEN. | OXYGEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127045141 | 12704514 | 1 | Chronic obstructive pulmonary disease |
| 127045141 | 12704514 | 2 | Chronic obstructive pulmonary disease |
| 127045141 | 12704514 | 3 | Product used for unknown indication |
| 127045141 | 12704514 | 5 | Diuretic therapy |
| 127045141 | 12704514 | 6 | Insomnia |
| 127045141 | 12704514 | 7 | Hypercholesterolaemia |
| 127045141 | 12704514 | 8 | Insomnia |
| 127045141 | 12704514 | 9 | Product used for unknown indication |
| 127045141 | 12704514 | 10 | Anxiolytic therapy |
| 127045141 | 12704514 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127045141 | 12704514 | OT |
| 127045141 | 12704514 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127045141 | 12704514 | Arterial occlusive disease | |
| 127045141 | 12704514 | Atrial fibrillation | |
| 127045141 | 12704514 | Atrioventricular block | |
| 127045141 | 12704514 | Bedridden | |
| 127045141 | 12704514 | Blood urine present | |
| 127045141 | 12704514 | Cardiac failure | |
| 127045141 | 12704514 | Cardiac murmur | |
| 127045141 | 12704514 | Catheter placement | |
| 127045141 | 12704514 | Chronic obstructive pulmonary disease | |
| 127045141 | 12704514 | Condition aggravated | |
| 127045141 | 12704514 | Emphysema | |
| 127045141 | 12704514 | Haemorrhage | |
| 127045141 | 12704514 | Hypotension | |
| 127045141 | 12704514 | Palliative care | |
| 127045141 | 12704514 | Product use issue | |
| 127045141 | 12704514 | Pulmonary oedema | |
| 127045141 | 12704514 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127045141 | 12704514 | 7 | 20160803 | 0 |